| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_567f6bd05206386260c7bdb76a2a5111 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 |
| filingDate |
2017-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1986639f148a3dd1ee74faac992f9041
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b96881248e4683c780e40752f81ba93
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dff96bf21553b238bbc8e3d9922a2b07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2b4b53447707392455224e4874a31f3 |
| publicationDate |
2018-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2018018950-A1 |
| titleOfInvention |
Novel application of gzd824 and pharmaceutically acceptable salts thereof in treating diseases |
| abstract |
Disclosed is an application of (3-((1H-pyrazol[3,4-b]pyridine-5-substituted)ethinyl)-4-methyl-N-(4-((4-methylpiperazine-1-substituted)methyl)-3-(trifluoromethyl)phenyl)benzamide) and pharmaceutically acceptable salts thereof in preparing drugs for treating acute lymphoblastic leukemia, and in particular, precursor B-cell lymphoblastic leukemia. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111249282-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111249282-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3713576-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022105836-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2019394218-B2 |
| priorityDate |
2016-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |